Authors: Sarafianos, SG Das, K Tantillo, C Clark, AD Ding, J Whitcomb, JM Boyer, PL Hughes, SH Arnold, E

Citation: Sg. Sarafianos et al., Crystal structure of HIV-1 reverse transcriptase in complex with a polypurine tract RNA : DNA, EMBO J, 20(6), 2001, pp. 1449-1461

Authors: Duan, CY Poticha, D Stoeckli, TC Petropoulos, CJ Whitcomb, JM McHenry, CS Kuritzkes, DR

Citation: Cy. Duan et al., Inhibition of purified recombinant reverse transcriptase from wild-type and zidovudine-resistant clinical isolates of human immunodeficiency virus type 1 by zidovudine, stavudine, and lamivudine triphosphates, J INFEC DIS, 184(10), 2001, pp. 1336-1340

Authors: Havlir, DV Hellmann, NS Petropoulos, CJ Whitcomb, JM Collier, AC Hirsch, MS Tebas, P Sommadossi, JP Richman, DD

Citation: Dv. Havlir et al., Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimens, J AM MED A, 283(2), 2000, pp. 229-234

Authors: Petropoulos, CJ Parkin, NT Limoli, KL Lie, YS Wrin, T Huang, W Tian, H Smith, D Winslow, GA Capon, DJ Whitcomb, JM

Citation: Cj. Petropoulos et al., A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1, ANTIM AG CH, 44(4), 2000, pp. 920-928

Authors: Brown, AJL Precious, HM Whitcomb, JM Wong, JK Quigg, M Huang, W Daar, ES D'Aquila, RT Keiser, PH Connick, E Hellmann, NS Petropoulos, CJ Richman, DD Little, SJ

Citation: Ajl. Brown et al., Reduced susceptibility of human immunodeficiency virus type 1 (HIV-1) frompatients with primary HIV infection to nonnucleoside reverse transcriptaseinhibitors is associated with variation at novel amino acid sites, J VIROLOGY, 74(22), 2000, pp. 10269-10273

Authors: Little, SJ Daar, ES D'Aquila, RT Keiser, PH Connick, E Whitcomb, JM Hellmann, NS Petropoulos, CJ Sutton, L Pitt, JA Rosenberg, ES Koup, RA Walker, BD Richman, DD

Citation: Sj. Little et al., Reduced antiretroviral drug susceptibility among patients with primary HIVinfection, J AM MED A, 282(12), 1999, pp. 1142-1149